pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: Spread of a monoresistant strain in Quebec, Canada

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 528-532

  Cheng, Shao Ji ^a   Thibert, Louise ^b   Sanchez, Tracy ^c   Heifets, Leonid ^c   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PYRAZINAMIDE; QUEBEC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034003580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.528-532.2000     Document Type: Article

References (24)

1. Heifets, L. B. 1991. Drug susceptibility tests in the management of chemotherapy of tuberculosis, p. 89-122. In L. B. Heifets (ed.), Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, Fla.
2. Heifets, L. B. 1999. Pyrazinamide, p. 668-676. In V. L. Yu, T. C. Merigan, and S. L. Barriere (ed.), Antimicrobial therapy and vaccines. Williams and Wilkins, Baltimore, Md.
3. Hewlett, D., D. L. Horn, and C. Alfalla. 1995. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273:916-917.
4. Hirano, K., M. Takahashi, Y. Kazumi, Y. Fukasawa, and C. Abe. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 78:117-122.
5. Konno, K., F. M. Feldman, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95: 461-469.
6. Lemaitre, N., W. Sougakoff, C. Truffot-Pernot, and V. Jarlier. 1999. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase. Antimicrob. Agents Chemother. 43:1761-1763.
7. Marttila, H. J., M. Marjamaki, E. Vyshnevskaya, B. I. Vishnevskiy, T. F. Otten, A. V. Vasilyef, and M. K. Viljanen. 1999. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwest Russia. Antimicrob. Agents Chemother. 43:1764-1766.
8. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20: 556-557.
9. McDermott, W., and R. Tompsett. 1954. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am. Rev. Tuberc. 70:748-754.
10. Mestdagh, M., P. A. Fonteyne, L. Realini, R. Rossau, G. Jannes, W. Mijs, K. A. L. De Smet, F. Portaels, and E. Van Den Eeckhout. 1999. Relationship between pyrazinmide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2317-2319.
11. Miller, M., L. Thibert, F. Desjardins, S. Siddiqi, and A. Dascal. 1995. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J. Clin. Microbiol. 33:2468-2470.
12. Mitchison, D. A. 1985. The action of antituberculosis drugs in short course chemotherapy. Tubercle 66:219-225.
13. Mizrahi, V., and S. Andersen. 1998. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol. Microbiol. 29:1331-1339.
14. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
15. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynaman, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
16. Sreevatsan, S., X. Pan, Y. Zhang, B. Kreiswirth, and J. M. Musser. 1997 Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41: 636-640.
17. Sun, Z. H., and Y. Zhang. 1999. Reduced pyrazinamidase and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Antimicrob. Agents Chemother. 43:537-542.
18. Tarshis, M. S., and W. A. Weed. 1953. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am. Rev. Tuberc. 67:391-395.
19. Trivedi, S. S., and S. G. Desai. 1987. Pyrazinamidase activity of Mycobacterium tuberculosis - a test of sensitivity to pyrazinamide. Tubercle 68:221-224.
20. van Soolingen, D., P. W. M. Hermans, E. W. de Haas, D. R. Soll, and J. D. A. van Embden. 1991. Occurrence and stability of insertion sequence in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
21. World Health Organization. 1995. WHO Report on the Tuberculosis Epidemic. Stop TB at the source. Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
22. Zhang, Y., M. J. Garcia, R. Lathigra, B. Allen, C. Moreno, J. D. A. van Embden, and D. Young. 1992. Alterations in the superoxide dismutase gene of an isoniazid-resistant strain of Mycobacterium tuberculosis. Infect. Immun. 60:2160-2165.
23. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London) 358:591-593.
24. Zhang, Y., A. Scorpio, H. Nikaido, and Z. H. Sun. 1999. Role of acid pH and deficient efflux of pyrazinoic acid in the unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J. Bacteriol. 181:2044-2049.